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FIGURE 1. Stent insertion was performed on both sides of the common carotid arteries.
Letters to the Editorhad sudden syncope. Neurologic ex-
amination showed paraplegia and
weakness of the right hand. Computed
tomography showed the presence of
type A aortic dissection with supra-
aortic arch branch dissection. The
left common carotid artery was
occluded by the compression of
thrombosed false lumen. Further-
more, infrarenal abdominal aorta was
also occluded through compression
by thrombosed false lumen. This
patient underwent emergency total
arch replacement and elephant trunk
insertion under hypothermic circula-
tory arrest and selective cerebral
perfusion. Five hours after surgery,
the patient was extubated with a stable
circulation; however, he reported
right-sided weakness. Emergency
computed tomography revealed that
the left common carotid artery was
still occluded and compressed by the
false lumen as previously. The right1302 The Journal of Thoracic andcommon carotid artery was dissected
as well, and the false lumen was
patent. Other branches of the aorta
were patent on this study. We per-
formed carotid artery stent insertion
on both sides of the common carotid
arteries (Figure 1). The patient recov-
ered without any neurologic deficit.
Management of cerebral malperfu-
sion remains a surgical challenge.2,3 If
intervention had been delayed in our
case, prognosis would not have been
optimistic.4 Our patient had multiple
malperfused arteries, so we did not
believe that distal malperfusion repair
should be done before aortic arch sur-
gery, because entry closure might be
able to improve distal malperfusion.
As Abe and colleagues1 described in
their article, central repair does not
always improve organ malperfusion,
as in our case. In this type of situation,
stent insertion to the malperfused
vessel could be another option.Cardiovascular Surgery c November 20Satoshi Numata, MD, PhD
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LOBECTOMY SAFE AND
SUCCESSFUL FOR LOCALLY
ADVANCED NON--SMALL
CELL LUNG CANCER?
To the Editor:
We read with interest the recent
article by Villamizar and colleagues.1
Their background is that video-
assisted thoracoscopic surgical (VATS)
lobectomy has been advocated as the
criterion standard for early stages of
non–small cell lung cancer (NSCLC),
but its role in locally advanced stages re-
mains to be determined. They therefore
focused on patients treated with VATS
lobectomy who had tumor size greater
than 3 cm, central location, or nodal
involvement to determine the predictive
impact of these factors on perioperative
morbidity. They compared the data
from these patients with data from pa-
tients who had tumor size smaller than
3 cm, peripheral location, or N0 stage.
We congratulate Villamizar and
colleagues1 for their huge experience13
Letters to the Editorof 1195 VATS lobectomies, their
excellent overall results (mortality,
1.6%; morbidity, 32%), and their
low conversion rate (4%). We also
congratulate them for the statistical
data analysis and for the propensity
score analysis that created homoge-
neous subclasses of patients to be
compared. Because the study was
retrospective, however, it should be
underlined that the decision to
perform VATS lobectomy in cases
with tumor size 3 cm, central disease,
or nodal involvement could have been
conditioned by the personal experi-
ence of the single surgeon. We would
like to focus attention on two topics.
First, when treating lung cancer the
key point is to guarantee the most
curative approach. Therefore the
main question should be whether
VATS lobectomy is oncologically
equivalent to open lobectomy, even
in locally advanced disease. In a
recent paper Hanna and colleagues2
reported their experience with 608
lobectomies (196 VATS and 412
open) for early-stage NSCLC and
concluded that overall and disease-
free survival did not differ between
open and thoracoscopic groups. Pal-
ade and associates3 compared the
effectiveness of nodal dissection be-
tween open and thoracoscopic surgery
in a small group of 66 patients. They
concluded that hilar and mediastinal
lymphadenectomy were equivalent.
We exhort Villamizar and colleagues1
to publish their oncologic survivals for
both techniques. In fact, data obtained
from such a large population of
patients treated should be very useful.
The second point concerns peri-
operative morbidity in the N-positive
group. According to Villamizar and
colleagues,1 nodal involvement was
the only variable that presented a
significant difference in perioperative
morbidity. In particular, it affected
the conversion rate (7.2% in N1–N3,
3.3% in N0) and the postoperative
transfusion rate. Unfortunately, Villa-
mizar and colleagues1 did not report
any data concerning number of nodesThe Journalinvolved, nodal size, and number of
the stations involved (hilar or medias-
tinal). These data could be significant
for surgeons who aim to adopt VATS
for locally advanced disease. More-
over, Villamizar and colleagues1 did
not report whether the involvement
was clinically or postoperatively
determined in N1 to N3 cases. It is still
our opinion that, independent of
surgical skill, perioperative morbidity
and disease-free survival could
be worse in the VATS group in case
of hilar disease or increased nodal
size.
In conclusion, the lesson of this
interesting article is that VATS
lobectomy may be equivalent to
open technique independent of T and
N status in terms of morbidity. The
operating surgeon must be always
ready for conversion, however, if
possible before significant bleeding.
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RECURRENCE RATES AND
UNDERLYING MECHANISMS
OF FUNCTIONAL MITRAL
REGURGITATION
To the Editor:
The recent publication by Kwon and
colleagues1 highlights the advantages
of complete ring annuloplasty relative
to partial ring annuloplasty in terms of
increasing durability and decreasing
recurrence rates. We appreciate the ef-
forts of Kwon and colleagues1 to figure
out the recurrence rate of functional
mitral regurgitationandunderlying fac-
tors that may help us to overcome spe-
cial issues encountered during surgical
treatment of the disease. After reading
the article several times carefully, we
would like to make further contribu-
tions to this issue in line with the state-
ments of Kwon and colleagues1 but
from a different point of view.
With regard to recurrence rates, the
currently accepted surgical treatment
option of undersized annuloplasty
has not yet matured. Thus it can be
assumed that there are still some
missing points needing to be clarified.
It is well known that the mitral
annulus is roughly circular in diastole,
and it becomes kidney shaped with an
anteroposterior (septolateral) diameter
smaller than the transverse diameter
during systole.A 26% 3% reduction
of mitral orifice area during systole re-
sults fromdisplacement of the aortomi-
tral curtain toward the center of the
orifice2; accordingly, the maximum
tension on the mitral annulus is at the
A2 to P2 direction in diastole and is
determined by septolateral dimension
changes during the cardiac cycle.3 Par-
tial rings cannot reduce the tension in
the A2 to P2 direction. It may thus be
speculated that they are insufficient to
stop the ongoing septolateral dimen-
sion changes, not only at the annular
level but also at the equatorial level of
the left ventricle. Tibayan and associ-
ates4 have suggested that the main
determinant of malcoaptation in func-
tional mitral regurgitation is the in-
crease in septolateral dimension. Thisy c Volume 146, Number 5 1303
